header
 

banner rdc

---------------------------------

The Pharmacist e-Link™ Continuing Education Center is designed to provide you with expanded online access to the highest quality of continuing education on a complimentary basis, through the convenience of the Velocity™ Online Learning Management System.


---------------------------------

banner norvasc

---------------------------------

Need Help logging into the Pharmacicst e-Link site?
Click Here for Registration and
Login Information

---------------------------------



banner rdc

This system allows you to search for relevant content from today’s leading providers in the world of continuing education, maintain your personal curriculum, bank your continuing education credits (both online and offline), track and print your professional transcript and more…


bullet Pharmacist e-Link CE Spotlight

thumbnail Awareness of Chronic Kidney Disease: An Introductory Program for Community Health Care Professionals
Chronic kidney disease is reaching epidemic proportions in the United States, and community practitioners are key to the early identification of these patients and those at risk for the development of CKD.
Commercial Support Provided by Genzyme.

thumbnail Compliance and Persistence in the Adult Asthma Patient
Effective modern treatment of asthma is about using the right dose of asthma medication at the right time. This program is designed to give the independent community pharmacist insight into the proper treatment and counseling of their adult asthma patients.
Commercial Support provided by AstraZeneca.

bullet Other Featured CE

thumbnail

Issues in Antiretroviral Therapy in the Treatment-Resistant Patient
This program will discuss drug therapy selection for the treatment-resistant patient. The AE, drug interaction, and pharmacokinetic profiles will be addressed. This topic is particularly important because advancements in the management of patients with HIV/AIDS have allowed individuals to live longer on medication therapy, and therefore, the issue of resistance is now more important than ever.
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

thumbnail

Current Therapeutic Trends in the Treatment of Chemotherapy-Induced Anemia
Anemia is common in cancer patients, but the impact is often poorly appreciated. It is a major cause of tumor hypoxia and also reduces the effectiveness of several anticancer therapies. This activity will discuss the strategies for incorporating clinical guidelines into practice and the safety and pharmacoeconomic issues surrounding treatment of anemia with ESFs.
Commercial Support provided by Amgen

thumbnail

The Power of Prevention: Lessons Learned from the Battle with Respiratory Syncytial Virus Disease
Respiratory Syncytial Virus (RSV) is an important cause of lower respiratory infections in young children and infants. This activity was designed to help physicians, pharmacists, nurses, and case managers better understand this illness and assist them in policy development and program design.
This activity is supported by an educational grant from MedImmune, Inc.
  Please click here to forward this newsletter to a friend